What can we learn from Biogen's decision to halt sales of aducanumab?
Richard G. Stefanacci, DO, MGH, MBA, AGSF, CMD
Advertisement
Articles by Richard G. Stefanacci, DO, MGH, MBA, AGSF, CMD
Advertisement
Latest Updated Articles
Current Implications for the Managed Care of DementiaPublished: December 1st 2007 | Updated:
- The Costs of Alzheimer's Disease and the Value of Effective Therapies
Published: November 11th 2011 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Cytokines Linked With Drug Resistance in Ovarian Cancer, but Underlying Mechanisms Remain Unclear
2
Mepolizumab Reduces Health Care Resource Utilization, Work Impairment in Severe Asthma
3
CHEST 2025 Highlights: Future of Respiratory Vaccines and the Impact of Federal Funding Cuts
4
Elinzanetant Shows Consistent Efficacy, Safety, and Sleep Benefits Across Studies
5
